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THE metabolism of 3: 4 benzpyrene within different structural components of
liver cells has already been studied by Calcutt and Payne (1954a, 1954b, 1954c
and 1954d). In relation to the problem of carcinogenesis the results recorded
in these papers are open to the criticism that the liver in both rats and mice is
effectively non-susceptible to the action of 3: 4 benzpyrene. The studies have
therefore been extended to cover kidney and skin.
Like the liver the kidney in rodents does not appear to be susceptible to hydro
carbon carcinogenesis, though Ilfeld (1936) obtained a number ofkidney tumours
in mice after insertion of pellets of 1I: 2: 5: 6 dibenzanthracene. The reason for
including this tissue in the present work is that Weigert and Mottram (1946)
found unchanged benzpyrene and benzpyrene metabolites in the kidneys of mice
which had received this hydrocarbon. These findings imply that metabolism
of the hydrocarbon can normally occur in this organ.
Skin is an obvious choice oftissue since from the data summarised by Hartwell
(1951) it is apparent that mouse skin readily responds to 3: 4 benzpyrene by
tumour induction, but that under similar experimental conditions rat skin is
refractory to the hydrocarbon.
From the aspect ofexperiments involving the separation ofcellular components
kidney is a tissue which is easily handled and has been extensively used in work
of this type. Skin on the otherhand is very difficult to homogenise and even after
homogenisation only two fractions are separable by centrifugation (Weist and
Heidelberger, 1953). One is composed of unbroken cells and the particulate
components of the disrupted cells whilst the other is a clear supernatant fraction.
However, Fiala, Sproul and Fiala (1955) showed that adequate separations can
be achieved ifthe skin ofvery young mice is used. This finding has been confirmed
and also extended to cover skin from day-old rats. So the skin experiments
reported later in this paper refer only to material derived from day-old animals.
EXPERIMENTAL
All tissues used in the experiments reported here were taken from RIII mice
or Wistar rats. Benzpyrene used in kidneyexperiments wasintheform ofacolloid
in distilled water at a concentration of 1 mg. per c.c. In the skin experiments
a 1 per cent solution in acetone was used, this solvent being chosen on the basis
of Pullinger's (1940) statement that cold acetone does not affect the microscopic
structure of mouse skin.
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Since the kidneys lie in the pathway of excretion via the urine the presence of
a compound in this organ does not necessarily imply its formation at this site.
The experiments concerned with metabolism in kidneys have therefore been
carried out under in vitro conditions. Kidneys were removed from freshly killed
rats or mice and homogenised in Tyrode or 0.88 M sucrose or 1 per cent citric acid
solution. The homogenate was then divided by centrifugation into fractions
comprising nuclei, mitochondria, microsomes and supernatant. Afterre-suspension
and washing each fraction was re-suspended in a small volume of the dispersing
medium together with some colloidal benzpyrene. The fractions were then placed
in an incubator at 370 C. in total darkness. After suitable time intervals the
fractions were removed and processed for benzpyrene metabolites as described
by Calcutt and Payne (1954b). The metabolites sought were those described
and labelled by Weigert and Mottram (1946) as BpX1 and BpX2. Identity of the
metabolites was based on a correspondence offluorescence colour, chromatographic
behaviour and absorption spectra with those recorded by Weigert and Mottram
(1946).
In the case of skin, the hydrocarbon in acetone solution was directly applied
to the back and flanks of groups of mice or rats which were not more than 24
hours old. After varying time intervals the animals were killed, the skin stripped
off with forceps and homogenised. After separation into nuclei, mitochondria,
microsomes and supernatant by centrifugation the individual fractions were
checked for the presence of benzpyrene metabolites as in the kidney experiments.
In this series of experiments all homogenisations were carried out in 1 per cent
citric acid as it was found that if 0.88 M sucrose or Tyrode were used almost the
entire particulate fraction sedimentedwith the nuclei on subsequent centrifugation.
With citric acid as the dispersing medium excellent separation of the individual
cell fractions was obtained.
Parallel to the above experiments the distribution of unchanged benzpyrene
within kidney and skin cells was also determined. In the case of kidney these
organs were removed from animals which had previously received intravenous
injections ofcolloidalbenzpyrene. Afterhomogenisation andcentrifugalseparation
into cell fractions each fraction was extracted with acetone until no further
fluorescent material was removed. The acetone was then boiled offfrom the pooled
washes under reduced pressure and the residue extracted with cyclohexane.
This was dried over anhydrous sodium sulphate and passed through a column of
alumina. Any benzpyrene present was held as a blue-violet fluorescent zone on
the column, and was readily eluted with ethyl alcohol. Final identification was
by absorption spectroscopy.
Using skin the problem is complicated by the presence of residual dried
hydrocarbon left after the painting. This can be removed by washing with organic
solvents but this causes hardening of the tissue and leads to difficulty with homo-
genisation. The expedient was adopted of preparing cell fractions from hydro-
carbon painted skin and then washing the individual fractions with acetone
till no further benzpyrene could be removed. Any hydrocarbon remaining must
be considered as firmly bound. Its release was effected by refluxing the fractions
for two hours in 50 per cent hydrochloric acid in the presence of red phosphorus
and potassium iodide, these being used in the proportions of 6: 2-5 by weight
and an obvious excess of the mixture was used with each fraction. Under these
conditions benzpyrene was released from the fractions and collected in the
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condenser from which it could be washed with cyclohexane in such a state of
purity as to be ready for estimation by absorption spectroscopy.
RESULTS
Metabolism in kidney cellfractions
The findings in these experiments are shown in Table I. Under the in vitro
conditions used benzpyrene was metabolised in all four cell fractions. The
benzpyrene metabolite, BpX2, was found in association with the nuclei, mito-
chondria and microsomes. In the supernatant fraction both BpX1 and BpX2
were present. These results are identical with those previously recorded by Calcutt
and Payne (1954b, 1954c and 1954d) for rat and mouse liver.
TABLE I.-Benzpyrene Metabolites in Kidney Fractions Incubated with Benzpyrene
Benpyrene metabolites in
Incuba-
Number tion Super-
of period Mito- Micro- natant
animals Sex (hrs.) Medium Nuclei chondria somes , -----
Mice . 12 M. 88 . Tyrode BpX2 BpX2 BpX2 BpXj BpX2
12 . F. . 64 1% citric acid BpX2 BpX2 BpX2 BpX1 BpX2
Rats 3 . M. 28 . Tyrode BpX2 BpX2 BpX2 BpX1 BpX2
3 F. . 34 . 0-88 M sucrose . BpX2 BpX2 BpX2 BpXj BpX2
Although these results indicate that kidney cell fractions have the same
potentialities for metabolising benzpyrene as the corresponding liver fractions
they do not show that metabolism occurs within the kidney in the intact animal.
If these findings are taken together with the previously mentioned evidence that
benzpyrene is deposited in the kidney it appears likely that metabolism occurs in
this organ.
Metabolism in skin
The skin from 34 day-old RIII mice which had been painted with 1 per cent
benzpyrene in acetone 23 hours earlier was separated into nuclei, mitochondria,
microsomes and supernatant. Each fraction was examined for benzpyrene
metabolites. The derivative BpX2 was found associated with all four fractions
but no BpX1 was detected.
In a comparable experimentwith 14day-oldrats allfourcellfractions contained
BpX2 but no BpXj was found.
This failure to find BpX1 was interesting but in agreement with the earlier
work of Weigert, Calcutt and Powell (1946, 1947) where BpX2 only was detected
in whole skin from benzpyrene treated mice. To attempt to obviate the possibility
that BpX1 is formed but only in very small amounts some further in vitro experi-
ments were undertaken.
Fractions from the skins of 60 mice were incubated for 32 hours in the presence
of benzpyrene and tetramethyluric acid. This last addition was based on Weil-
Malherbe's (1946) evidence showing that tetramethyluric acid has a remarkable
solvent power for 3: 4 benzpyrene. It was hoped by this method to increase the
penetration of the benzpyrene into the tissue fractions and thus increase meta-
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bolism. From the subsequent extractions BpX2 only was obtained; this being
associated with all fractions. In corresponding experiments with the skin of 12
rats incubated for 72 hours similar results were obtained. A further experiment
using skin from 13 rats (but without the addition of tetramethyluric acid) and
incubated for 16 hours gave identical results.
Distribution of benzpyrene within kidney cells
These findings derived from the kidneys of rats or mice which had received
previous intravenous injections of the colloidal hydrocarbon. The results are
given in Table II.
TABLE II.-Distribution of 3: 4 Benzpyrene in Mouse and Rat Kidneys
Bp - hydrocarbon present.
- - hydrocarbon absent.
Time
Number of
of killing Dispersal Mito- Micro- Super-
animals Sex (hrs.) medium Nuclei chondria somes natant
Mice. 10 F. 1½ 1%citric acid . Bp . Bp Bp . Bp
8 . M. . 4 0-88 Msucrose. Bp . Bp Bp Bp
9 . F. . 16 . Tyrode Bp . Bp -
Rats. 2 . M. . 2 . Tyrode . Bp Bp . Bp Bp
2 . F. . 5 . 0-88 M sucrose . Bp Bp Bp . Bp
2 . ,, 18 . 1% citric acid . Bp . Bp Bp . --
Distribution of benzpyrene within skin cells
It has already been shown by Fiala, Sproul and Fiala (1955) that benzpyrene
penetrates to and is bound in nuclei, mitochondria, microsomes and supernatant
ofmouse skin cells. In the present experiments the hydrocarbon has been detected
in all four fractions of rat skin cells 21, 6 and 22 hours after painting with the
hydrocarbon.
DISCUSSION
The results recorded in the foregoing paragraphs show a remarkable resemb-
lance to those previously recorded by Calcutt and Payne (1954b, 1954c, 1954d) in
respect of similar work involving liver cells.
As in the liver experiments the hydrocarbon was found to penetrate throughout
the cell in both kidney and skin. The formation ofbenzpyrene X2 takes place in
all four cell fractions as in the liver, but although BpX1 was found in the super-
natant fraction from kidneys no trace of this derivative was obtained in skin. It
can be said then that the intracellular behaviour of benzpyrene in kidney cells is
identical with that in liver cells of both rats and mice. In skin cells, although the
general pattern is similar, a distinction appears in that the metabolic derivative
BpX1 is no longer found.
Since BpX1 is formed in both liver and kidney, where tumour induction by
polycyclic hydrocarbons is a rare occurrence, but is not formed in skin which is
susceptible to the carcinogenic action ofbenzpyrene it appears that this derivative
can play no part in the carcinogenic process. Therefore, Boyland and Weigert's
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(1947) proposal that BpX1 or its immediate breakdown product, BpFj, is the
proximate carcinogenic agent is no longer tenable. BpXj would now appear to
be a mere detoxication product.
Boyland (1950) has collected evidence indicative of a causal relationship
between metabolism of carcinogens and their carcinogenic activity. If this is
accepted it would now appear, in the light of the new evidence that the carcino-
genecity of benzpyrene is associated with either the formation of the derivative
BpX2 or with the formation of some as yet unknown derivative. In relation to
this second possibility Tarbell, Brooker, Seifert, Vanterpool, Claus and Conway
(1956) have offered some evidence for a further, as yet unidentified, benzpyrene
metabolite being formed in mouse skin.
Pullinger (1940) described nuclear abnormalities as occurring in mouse skin
after application of benzpyrene, and it has now been shown that skin cell nuclei
not only absorb the hydrocarbon but also metabolise it. Under these circum-
stances it is feasible that the nuclear derangements induced by benzpyrene are
the result of activity within the nucleus itself.
An interesting point arising from the present work is the fact that no differences
were detected in the behaviour of benzpyrene in rat or mouse skin cells. Yet
the adult rat skin is refractory to hydrocarbon carcinogenesis whilst mouse skin
is susceptible. The answer to this problem may lie in the fact that the present
experiments have been concerned with skin from very young animals. Fiala,
SproulandFiala (1955) statedthat day-old micepaintedwithbenzpyreneresponded
with tumour formation, but there appear to be no records of similar experiments
with young rats.
The similarities of behaviour of benzpyrene in liver, kidney and skin cells
as contrasted with the difference in biological response of skin as compared with
the other tissues leaves further problems which require more experimental work.
SUMMARY
1. Benzpyrene has been found to be metabolised to the derivative BpX2 in
nuclei, mitochondria, microsomes and supernatant of kidney and skin cells from
rats and mice.
2. The derivative BpXj was found to be formed in the supernatant fraction
ofkidney cells ofboth rats and mice but never to occur in skin.
3. Unchanged benzpyrene penetrates to nuclei, mitochondria, microsomes
and supernatant ofkidney and skin cells ofboth rats and mice.
4. It is concluded that the benzpyrene derivative, BpX,, has no association
with the carcinogenic activity of the hydrocarbon.
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